Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Curaleaf Officially Opens First Medical Cannabis Dispensary in Reisterstown

Curaleaf
Posted on: 23 Mar 18

Today, Curaleaf celebrates the official opening of its medical cannabis dispensary in Reisterstown. The company will make safe, effective, reliable and innovative cannabis-based therapeutic products more easily accessible, in addition to offering multiple education resources to patients and doctors. The new facilities will also feature private consultation rooms to guide patients and ensure the best cannabinoid therapy for their symptoms. The company’s first dispensary in Maryland, Curaleaf’s Reisterstown location joins multiple Curaleaf dispensaries across the country providing medical care.

Justin Somers, the newly appointed Curaleaf President for Maryland and Pennsylvania, was joined by representatives from The Northwest Chamber of Commerce to cut the opening ribbon, welcoming patients into the brand new facility located at 11722 Reisterstown Rd.

"The Northwest Chamber is pleased to welcome Curaleaf to our community. We wish them every success in their compassionate mission," said Sally Shapiro-Gould, President of The Northwest Chamber of Commerce.

“Curaleaf has received a warm welcome from Reisterstown,” said Justin Somers, Curaleaf President. “Curaleaf is committed to delivering premium and reliable medical cannabis products in a compassionate and caring environment. With this new location, we will make this needed medical aid accessible to more members of the Maryland community.”

“In my practice, we’ve seen patients decrease or discontinue opioids used for pain management by using cannabis. It’s a great option for everyone with chronic pain,” said Evelyn Blaemire, nurse practitioner and owner of Chronic Connections. “This Curaleaf dispensary will be a great resource for patients, and its employees will help patients to better choose products that deliver relief while minimizing unwanted side effects.”

Occupying 3,969 square-feet, the bright and welcoming space is the perfect environment to purchase Curaleaf’s full spectrum of legal cannabis products, from low- to high-THC products, CBD and 1:1 products. Medical cannabis products are available in the forms of cartridges, syringes, tinctures, tablets, flower/pre-rolls and vaporizer pens. Discount programs are in effect for pediatric patients, military veterans, senior citizens and recipients of government financial assistance. You can download photos here.

About Curaleaf
Led by a team of physicians, pharmacists, medical experts and industry visionaries, Curaleaf develops safe, effective, and innovative cannabis-based therapeutic products. Curaleaf combines the industry's most medically precise and technologically advanced production techniques, ensure consistently exceptional quality that patients and health care professionals can trust. Based on a foundation of compassion, professionalism and respect, Curaleaf strives to empower health care professionals and patients by providing product expertise and guidance to help them make the right choices. Curaleaf is committed to being the industry’s leading resource in education and advancement of medical cannabis through research and advocacy. Currently, Curaleaf manages multiple dispensaries across five states. More information regarding Curaleaf can be found at www.curaleaf.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180323005086/en/

Business Wire
www.businesswire.com

Last updated on: 23/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.